|
TOP 5 INSIGHTS IN DRUG FORMULATION AND DELIVERY
NOVEMBER EDITION
|
|
|
|
|
|
Fran DeGrazio recounts the evolution of drug delivery technologies as she underscores the need to innovate in the delivery of advanced therapies. Fran offers suggestions for organizing and readying for the development and delivery of platforms, systems, and devices for next generation treatments, including personalized, precision medicines.
|
|
|
|
|
|
This article breaks down how to achieve a “right first time” regulatory submission for device-focused combination products by aligning early on goals, strategy, and cross-functional collaboration. Learn how to build a smarter, more successful regulatory strategy.
|
|
|
|
|
|
Exosome-based RNA therapeutics are rapidly evolving, and NurExone’s CNS-focused approach shows how these natural nanoparticles could enable minimally invasive treatments for spinal cord and nerve injuries once thought untreatable. Learn more about their ExoTherapy platform.
|
|
|
|
|
|
Discover why a medical device’s “total user interface”—including the device, packaging, labeling, and IFU—must work together to prevent use errors and improve real-world safety. Read the full article to learn how a system-level approach can transform user understanding and outcomes.
|
|
|
|
|
|
This interview with MIT Institute Professor Robert Langer offers an inspiring look at his groundbreaking impact on drug delivery and tissue engineering, along with candid reflections on NAMs, longevity, and the future of biomedical innovation. Don’t miss his insights — and a surprising magic trick.
|
|
|
|
|